NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/13/2023
Back to search
Official data from USPTO
STELLAR TRIALBRIDGE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
06/13/2023
Trademark type
Combined
Nice classes
42
Filing date
03/22/2021
Registration date
06/13/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2023
Last transaction
06/13/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/14/2022
First use in commerce
12/14/2022
Drawing code
3
Owner type
03
Owner location
ROCKVILLE, MD
Examiner
KELLY, JOHN M
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "Stellar TrialBridge" in stylized font with a horizontal line between the words, and a stylized laboratory flask featuring two double helix designs and seven shaded hexagons shapes, two of which are connected.
Holders and representatives
Holders
STELLAR IDEA LABS, INC.
greatEvents, LLC
Representatives
Prof. Dr. Raj S. Davé DAVÉ LAW GROUP, LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Software as a service (SAAS) services featuring software for use in managing data and information in the field of medical clinical trials and researchfor use in clinical trial monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and researchfor use in clinical data capturemanagement and reporting in the nature of the results of medical clinical trials and research; providing online non-downloadable software for use in managing data and information in the field of medical clinical trials and researchclinical trial design and protocol developmentclinical trial planning and managementclinical trial user and learning managementclinical trial operational reporting and analyticsclinical trial randomization and trial supply managementclinical trial monitoring and events capture and clinical data capturemanagement and reporting; Application service provider (ASP) featuring software using artificial intelligence for use in managing data and information in the field of medical clinical trials and researchfor use in clinical trial monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and researchfor use in clinical data capturemanagement and reporting in the nature of the results of medical clinical trials and research; Conducting clinical trials for others; Conducting early evaluations in the field of new pharmaceuticals; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of pharmaceuticals and medical devicesdesigningorganizingconductingmonitoringmanaging clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; Medical and scientific researchconducting clinical trials for others; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Platform as a service (PAAS) featuring computer software platforms for use in managing data and information in the field of medical clinical trials and researchfor use in clinical trial monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and researchfor use in clinical data capturemanagement and reporting in the nature of the results of medical clinical trials and research; Providing information on clinical studies via an interactive website; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Scientific research and development; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/12/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/09/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/10/2023
GNRT
NON-FINAL ACTION E-MAILED
02/10/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
02/10/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/18/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/18/2023
IUAF
USE AMENDMENT FILED
12/14/2022
EISU
TEAS STATEMENT OF USE RECEIVED
12/14/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/14/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/19/2022
PUBO
PUBLISHED FOR OPPOSITION
04/19/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/30/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/17/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/15/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/15/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/15/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/15/2021
GNRT
NON-FINAL ACTION E-MAILED
11/15/2021
CNRT
NON-FINAL ACTION WRITTEN
11/15/2021
DOCK
ASSIGNED TO EXAMINER
09/10/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/25/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/24/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/07/2021
NWAP
NEW APPLICATION ENTERED
03/25/2021
Continuous trademark protection
Get notified about every new filing that threatens STELLAR TRIALBRIDGE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.